SLS Sellas Life Sciences Group Inc
Company Analysis
Latest News
Sellas Life Sciences Drops 10% on REGAL Trial Anxiety — But Is the Delay Actually Good News in Disguise?
Shares of Sellas Life Sciences (SLS) slid 10.1% to $10.18 on Monday as investors bailed out amid growing unease that top-line data from the company's...
🔴 Sellas Life Sciences is trading 10.1% down today on Phase 3 REGAL AML delay concerns
Sellas Life Sciences is trading 10.1% down at $10.18 as investors react to perceived delays in the Phase 3 REGAL AML trial data release. • Traders are focused...
🔴 Sellas Life Sciences is trading 5.48% down today on Phase 3 REGAL AML trial delay concerns
Sellas Life Sciences is trading at $10.70 (-5.48%) as shares extend a pullback driven by investor uncertainty regarding clinical trial timelines. • Market...
🔴 Sellas Life Sciences is trading 4.4% down today on reports of potential Phase 3 trial data delays
Sellas Life Sciences is trading 4.4% down at $11.80 following online commentary suggesting a potential delay in the release of its Phase 3 REGAL trial data for...
Sellas Shares Sink, Martin Shkreli Predicts AML Trial Delay
Sellas Life Sciences shares fell after former hedge fund manager Martin Shkreli questioned the timing of its Phase 3 REGAL trial. Shkreli suggested on social...
🟢 Sellas Life Sciences is trading 5.1% up
Sellas Life Sciences is trading at $12.70, up 5.1% from a comparison close of $12.08 during regular trading. This is a price-action follow-up, so a separate...
Sellas Investor Slashes Stake by 33%, Ahead of Pivotal Cancer Data
Fulcrum Wealth Advisors reduced its stake in Sellas Life Sciences by 33%, according to reports published late Tuesday and early Wednesday. The wealth advisor...
Sellas Life Sciences Enters Quiet Period, Sparking AML Takeover Speculation
CEO Angelos Stergiou confirmed Sellas Life Sciences is nearing the 80th event in its Phase 3 Regal trial. This milestone triggers the final data analysis for...
🟢 Sellas Life Sciences is trading 4.1% up today, rebounding from dilution fears as the biotech sector rallies
Sellas Life Sciences is trading at $12.98 (up 4.1%) as the stock recovers from a recent selloff triggered by a 20 million-share equity plan expansion and CEO...
🔴 Sellas Life Sciences is trading 5.8% down today on dilution concerns from 20 million new share authorization
Sellas Life Sciences is trading 5.8% down now at $12.43 after shareholders approved the issuance of 20 million new shares for employee compensation, raising...
🟢 Sellas Life Sciences is trading 10.5% up
Sellas Life Sciences is trading at $12.98, up 10.5% from a comparison close of $11.75 during regular trading. This is a price-action follow-up, so a separate...
🟢 Sellas Life Sciences is trading 7.7% up today ahead of pivotal leukemia trial survival readout
Sellas Life Sciences is trading 7.7% up at $12.65 as traders reposition ahead of a pivotal survival readout from the Phase 3 REGAL trial. • The upcoming data...
Sellas Life Sciences Slides 6% as the Biggest Binary Bet in Small-Cap Biotech Inches Toward a Verdict — Is the Market Pricing It Right?
Shares of Sellas Life Sciences (SLS) dropped to $12.03, down 6.0%, as traders continue to jostle for position ahead of what could be the most consequential...
🔴 Sellas Life Sciences is trading 6.6% down today as traders take profits ahead of trial results
Sellas Life Sciences is trading 6.6% down today at $12.03 as investors rebalance risk and take profits following a period of heavy volatility. • Shares are...
Sellas Life Sciences surges, as $5.8M options bet precedes leukemia trial results
Sellas Life Sciences (SLS) shares rose after Armstrong Advisory Group disclosed a new institutional position. The stock also experienced a significant increase...
🔴 Sellas Life Sciences is trading 5.2% down
Sellas Life Sciences is trading at $12.69, down 5.2% from a comparison close of $13.39 during regular trading. This is a price-action follow-up, so a separate...
🟢 Sellas Life Sciences is trading 4.0% up today amid trading volatility and biotech sector positioning
Sellas Life Sciences is trading at $13.13 (+4.04%) as the stock gains momentum following a volatile stretch and a move off its recent lows. • The stock has...
🔴 Sellas Life Sciences Shares Decline Amid Volatility as Investors Weigh Phase 3 REGAL Trial Progress and Conflicting Analyst Outlooks
• Sellas Life Sciences is trading at $12.85 (-4.89%) today, extending a sharp pullback from early July trading. • The decline comes as investors continue to...
🟢 Sellas Life Sciences is trading 4.9% up today as it rebounds amid broader market gains
Sellas Life Sciences is trading 4.9% higher at $14.44 as the stock rebounds from recent volatility despite a lack of fresh company-specific catalysts. • The...
🔴 SLS extends move to 7.4% down
SLS is trading at $12.50, down 7.4% versus the comparison close of $13.50 during regular trading. This is a price-movement alert; no separate company-specific...